ORIENT BIO Inc. (KOSE: A002630)
Health Care · Life Sciences Tools & Services · KR
₩1,638.00
-0.12% today · -26.7% 1Y
ORIENT BIO Inc. (KOSE: A002630) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $36.12M.
Over the last twelve months the share price has lost 26.7%, trading between 1.49K and 3.26K.
Tweenvest scores ORIENT BIO Inc. across four factors: quality 59/100, value 48/100, growth 76/100. Its strongest factor is growth.
A002630 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $36.12M
- Revenue (TTM)
- $49.61M
- P/E
- —
- EPS
- -231.23
- Dividend yield
- —
- Beta (5Y)
- 0.00
- 52-week high
- ₩3,264.00
- 52-week low
- ₩1,490.00
- Avg volume (3M)
- —
- Shares outstanding
- 29.64M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cyfuse Biomedical K.K.TSE: 4892 | $39.14M | ¥622.00 | -5.04% |
| CellSource Co., Ltd.TSE: 4880 | $38.99M | ¥311.00 | +1.30% |
| Arch Biopartners Inc.OTCPK: ACHF.F | $38.26M | $0.56 | -1.30% |
| Harvard Bioscience, Inc.NasdaqCM: HBIO | $37.51M | $8.49 | +3.03% |
| P&K Skin Research Center Co., Ltd.KOSDAQ: A347740 | $36.09M | ₩1,680.00 | +1.82% |
| Green Lifescience Co., Ltd.KOSDAQ: A114450 | $34.86M | ₩2,400.00 | +4.80% |
| Malin Corporation plcISE: MLC | $33.98M | €7.00 | +2.94% |
| Trajan Group Holdings LimitedASX: TRJ | $30.40M | AU$0.29 | +21.28% |
Figures last refreshed Oct 11, 2026.